Selected research
Market Outlook & Growth Opportunities
Global Atracurium Market Outlook and Growth Opportunities 2026
Market perspective
The global Atracurium market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Atracurium is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Atracurium is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Atracurium is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Atracurium market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Atracurium market include HOSPIRA, Joshi & Company, ZHEJIANG HAISEN PHARMACEUICAL, GSK, Jiangsu Hengrui Medicine, Dongying (Jiangsu) Pharmaceutical and Zhejiang Xianju Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Atracurium market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Atracurium and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Atracurium sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Atracurium market size, projected growth trends, production technologies, key applications, and end-use industries.
Atracurium Segment by Company
HOSPIRA
Joshi & Company
ZHEJIANG HAISEN PHARMACEUICAL
GSK
Jiangsu Hengrui Medicine
Dongying (Jiangsu) Pharmaceutical
Zhejiang Xianju Pharmaceutical
Atracurium Segment by Type
25mg
50mg
Atracurium Segment by Application
Clinic
Hospital
ASCs
Others
Atracurium Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Atracurium status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Atracurium market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Atracurium significant trends, drivers, influence factors in global and regions.
6. To analyze Atracurium competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Atracurium market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Atracurium and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Atracurium.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Atracurium market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Atracurium industry.
Chapter 3: Detailed analysis of Atracurium manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Atracurium in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Atracurium in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- 25mg
- 50mg
Applications
- Clinic
- Hospital
- ASCs
- Others
Companies covered
- HOSPIRA
- Joshi & Company
- ZHEJIANG HAISEN PHARMACEUICAL
- GSK
- Jiangsu Hengrui Medicine
- Dongying (Jiangsu) Pharmaceutical
- Zhejiang Xianju Pharmaceutical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Atracurium Sales Value (2021-2032)
- 1.2.2 Global Atracurium Sales Volume (2021-2032)
- 1.2.3 Global Atracurium Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Atracurium Market Dynamics
- 2.1 Atracurium Industry Trends
- 2.2 Atracurium Industry Drivers
- 2.3 Atracurium Industry Opportunities and Challenges
- 2.4 Atracurium Industry Restraints
3 Atracurium Market by Company
- 3.1 Global Atracurium Company Revenue Ranking in 2025
- 3.2 Global Atracurium Revenue by Company (2021-2026)
- 3.3 Global Atracurium Sales Volume by Company (2021-2026)
- 3.4 Global Atracurium Average Price by Company (2021-2026)
- 3.5 Global Atracurium Company Ranking (2024-2026)
- 3.6 Global Atracurium Company Manufacturing Base and Headquarters
- 3.7 Global Atracurium Company Product Type and Application
- 3.8 Global Atracurium Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Atracurium Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Atracurium Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Atracurium Market by Type
- 4.1 Atracurium Type Introduction
- 4.1.1 25mg
- 4.1.2 50mg
- 4.2 Global Atracurium Sales Volume by Type
- 4.2.1 Global Atracurium Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Atracurium Sales Volume by Type (2021-2032)
- 4.2.3 Global Atracurium Sales Volume Share by Type (2021-2032)
- 4.3 Global Atracurium Sales Value by Type
- 4.3.1 Global Atracurium Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Atracurium Sales Value by Type (2021-2032)
- 4.3.3 Global Atracurium Sales Value Share by Type (2021-2032)
5 Atracurium Market by Application
- 5.1 Atracurium Application Introduction
- 5.1.1 Clinic
- 5.1.2 Hospital
- 5.1.3 ASCs
- 5.1.4 Others
- 5.2 Global Atracurium Sales Volume by Application
- 5.2.1 Global Atracurium Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Atracurium Sales Volume by Application (2021-2032)
- 5.2.3 Global Atracurium Sales Volume Share by Application (2021-2032)
- 5.3 Global Atracurium Sales Value by Application
- 5.3.1 Global Atracurium Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Atracurium Sales Value by Application (2021-2032)
- 5.3.3 Global Atracurium Sales Value Share by Application (2021-2032)
6 Atracurium Regional Sales and Value Analysis
- 6.1 Global Atracurium Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Atracurium Sales by Region (2021-2032)
- 6.2.1 Global Atracurium Sales by Region: 2021-2026
- 6.2.2 Global Atracurium Sales by Region (2027-2032)
- 6.3 Global Atracurium Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Atracurium Sales Value by Region (2021-2032)
- 6.4.1 Global Atracurium Sales Value by Region: 2021-2026
- 6.4.2 Global Atracurium Sales Value by Region (2027-2032)
- 6.5 Global Atracurium Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Atracurium Sales Value (2021-2032)
- 6.6.2 North America Atracurium Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Atracurium Sales Value (2021-2032)
- 6.7.2 Europe Atracurium Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Atracurium Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Atracurium Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Atracurium Sales Value (2021-2032)
- 6.9.2 South America Atracurium Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Atracurium Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Atracurium Sales Value Share by Country, 2025 VS 2032
7 Atracurium Country-level Sales and Value Analysis
- 7.1 Global Atracurium Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Atracurium Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Atracurium Sales by Country (2021-2032)
- 7.3.1 Global Atracurium Sales by Country (2021-2026)
- 7.3.2 Global Atracurium Sales by Country (2027-2032)
- 7.4 Global Atracurium Sales Value by Country (2021-2032)
- 7.4.1 Global Atracurium Sales Value by Country (2021-2026)
- 7.4.2 Global Atracurium Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Atracurium Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Atracurium Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Atracurium Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Atracurium Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Atracurium Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Atracurium Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Atracurium Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Atracurium Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Atracurium Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Atracurium Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Atracurium Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Atracurium Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Atracurium Sales Value Growth Rate (2021-2032)
- 7.9.2 France Atracurium Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Atracurium Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Atracurium Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Atracurium Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Atracurium Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Atracurium Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Atracurium Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Atracurium Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Atracurium Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Atracurium Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Atracurium Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Atracurium Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Atracurium Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Atracurium Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Atracurium Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Atracurium Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Atracurium Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Atracurium Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Atracurium Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Atracurium Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Atracurium Sales Value Growth Rate (2021-2032)
- 7.16.2 China Atracurium Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Atracurium Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Atracurium Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Atracurium Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Atracurium Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Atracurium Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Atracurium Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Atracurium Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Atracurium Sales Value Growth Rate (2021-2032)
- 7.19.2 India Atracurium Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Atracurium Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Atracurium Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Atracurium Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Atracurium Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Atracurium Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Atracurium Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Atracurium Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Atracurium Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Atracurium Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Atracurium Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Atracurium Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Atracurium Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Atracurium Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Atracurium Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Atracurium Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Atracurium Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Atracurium Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Atracurium Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Atracurium Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Atracurium Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Atracurium Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Atracurium Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Atracurium Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Atracurium Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Atracurium Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Atracurium Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Atracurium Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Atracurium Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Atracurium Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Atracurium Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Atracurium Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Atracurium Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Atracurium Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Atracurium Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Atracurium Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Atracurium Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Atracurium Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Atracurium Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Atracurium Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Atracurium Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 HOSPIRA
- 8.1.1 HOSPIRA Company Information
- 8.1.2 HOSPIRA Business Overview
- 8.1.3 HOSPIRA Atracurium Sales, Value and Gross Margin (2021-2026)
- 8.1.4 HOSPIRA Atracurium Product Portfolio
- 8.1.5 HOSPIRA Recent Developments
- 8.2 Joshi & Company
- 8.2.1 Joshi & Company Company Information
- 8.2.2 Joshi & Company Business Overview
- 8.2.3 Joshi & Company Atracurium Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Joshi & Company Atracurium Product Portfolio
- 8.2.5 Joshi & Company Recent Developments
- 8.3 ZHEJIANG HAISEN PHARMACEUICAL
- 8.3.1 ZHEJIANG HAISEN PHARMACEUICAL Company Information
- 8.3.2 ZHEJIANG HAISEN PHARMACEUICAL Business Overview
- 8.3.3 ZHEJIANG HAISEN PHARMACEUICAL Atracurium Sales, Value and Gross Margin (2021-2026)
- 8.3.4 ZHEJIANG HAISEN PHARMACEUICAL Atracurium Product Portfolio
- 8.3.5 ZHEJIANG HAISEN PHARMACEUICAL Recent Developments
- 8.4 GSK
- 8.4.1 GSK Company Information
- 8.4.2 GSK Business Overview
- 8.4.3 GSK Atracurium Sales, Value and Gross Margin (2021-2026)
- 8.4.4 GSK Atracurium Product Portfolio
- 8.4.5 GSK Recent Developments
- 8.5 Jiangsu Hengrui Medicine
- 8.5.1 Jiangsu Hengrui Medicine Company Information
- 8.5.2 Jiangsu Hengrui Medicine Business Overview
- 8.5.3 Jiangsu Hengrui Medicine Atracurium Sales, Value and Gross Margin (2021-2026)
- 8.5.4 Jiangsu Hengrui Medicine Atracurium Product Portfolio
- 8.5.5 Jiangsu Hengrui Medicine Recent Developments
- 8.6 Dongying (Jiangsu) Pharmaceutical
- 8.6.1 Dongying (Jiangsu) Pharmaceutical Company Information
- 8.6.2 Dongying (Jiangsu) Pharmaceutical Business Overview
- 8.6.3 Dongying (Jiangsu) Pharmaceutical Atracurium Sales, Value and Gross Margin (2021-2026)
- 8.6.4 Dongying (Jiangsu) Pharmaceutical Atracurium Product Portfolio
- 8.6.5 Dongying (Jiangsu) Pharmaceutical Recent Developments
- 8.7 Zhejiang Xianju Pharmaceutical
- 8.7.1 Zhejiang Xianju Pharmaceutical Company Information
- 8.7.2 Zhejiang Xianju Pharmaceutical Business Overview
- 8.7.3 Zhejiang Xianju Pharmaceutical Atracurium Sales, Value and Gross Margin (2021-2026)
- 8.7.4 Zhejiang Xianju Pharmaceutical Atracurium Product Portfolio
- 8.7.5 Zhejiang Xianju Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Atracurium Value Chain Analysis
- 9.1.1 Atracurium Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Atracurium Sales Mode & Process
- 9.2 Atracurium Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Atracurium Distributors
- 9.2.3 Atracurium Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst